BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22141346)

  • 21. [Intravenous lacosamide in monotherapy in a case of complex partial epileptic status].
    Granda-Méndez J; Toledo M; Flores-Flores A; Santamarina E; Sarria S; Salas-Puig J
    Rev Neurol; 2011 Jul; 53(1):61-3; authors reply 64. PubMed ID: 21678328
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of lacosamide on the quality of life of patients with epilepsy].
    García-Escrivá A; López-Hernández N; Llorca V; Alfaro A; Asensio-Asensio M; García C; Lezcano-Rodas M; Medrano V; Palao S
    Rev Neurol; 2014 Aug; 59(4):145-52. PubMed ID: 25059264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.
    Rudd GD; Haverkamp W; Mason JW; Wenger T; Jay G; Hebert D; Doty P; Horstmann R
    Acta Neurol Scand; 2015 Nov; 132(5):355-63. PubMed ID: 25933358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
    Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
    Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
    García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
    Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacosamide for the treatment of partial-onset seizures.
    Biton V
    Expert Rev Neurother; 2012 Jun; 12(6):645-55. PubMed ID: 22650166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
    Simoens S
    Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid loading of intravenous lacosamide: efficacy and practicability during presurgical video-EEG monitoring.
    Li W; Stefan H; Matzen J; Rampp S; Heinze HJ; Schmitt FC
    Epilepsia; 2013 Jan; 54(1):75-80. PubMed ID: 22998639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
    Degiorgio CM
    Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lacosamide--oral administration (Vimpat) ].
    Duh D; Peeters S
    J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
    [No Abstract]   [Full Text] [Related]  

  • 34. Lacosamide-induced valproic acid toxicity.
    Jones GL; Popli GS; Silvia MT
    Pediatr Neurol; 2013 Apr; 48(4):308-10. PubMed ID: 23498565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacosamide-induced rash.
    Koubeissi MZ; Vismer M; Ehrlich A
    Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacosamide treatment of juvenile myoclonic epilepsy.
    Afra P; Adamolekun B
    Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with lacosamide in a series of children with drug-resistant focal epilepsy.
    Guilhoto LM; Loddenkemper T; Gooty VD; Rotenberg A; Takeoka M; Duffy FH; Coulter D; Urion D; Bourgeois BF; Kothare SV
    Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toothbrushing-induced seizures at onset of cryptogenic partial epilepsy: a case report.
    Ott DV; Kauert A; Holtkamp M
    J Neurol; 2014 Feb; 261(2):432-4. PubMed ID: 24368403
    [No Abstract]   [Full Text] [Related]  

  • 39. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA.
    Villanueva V; López-Gomáriz E; López-Trigo J; Palau J; García M; Villarroya T; Bonet M; Santafé C
    Epilepsy Behav; 2012 Mar; 23(3):298-304. PubMed ID: 22370116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.